112 related articles for article (PubMed ID: 7530208)
1. Characterization of tachykinin mediated increases in [Ca2+]i in Chinese hamster ovary cells expressing human tachykinin NK3 receptors.
Pinnock RD; Suman-Chauhan N; Chung FZ; Webdale L; Madden Z; Hill DR; Woodruff GN
Eur J Pharmacol; 1994 Sep; 269(1):73-8. PubMed ID: 7530208
[TBL] [Abstract][Full Text] [Related]
2. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
[TBL] [Abstract][Full Text] [Related]
3. Tachykinins increase [3H]acetylcholine release in mouse striatum through multiple receptor subtypes.
Preston Z; Lee K; Widdowson L; Richardson PJ; Pinnock RD
Neuroscience; 2000; 95(2):367-76. PubMed ID: 10658616
[TBL] [Abstract][Full Text] [Related]
4. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
Emonds-Alt X; Proietto V; Steinberg R; Advenier C; Daoui S; Naline E; Gueudet C; Michaud JC; Oury-Donat F; Poncelet M; Vilain P; Le Fur G; Maffrand JP; Soubrié P; Pascal M
Can J Physiol Pharmacol; 2002 May; 80(5):482-8. PubMed ID: 12056557
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.
Suman-Chauhan N; Grimson P; Guard S; Madden Z; Chung FZ; Watling K; Pinnock R; Woodruff G
Eur J Pharmacol; 1994 Sep; 269(1):65-72. PubMed ID: 7530207
[TBL] [Abstract][Full Text] [Related]
7. Further identification of neurokinin receptor types and mechanisms of calcium signaling evoked by neurokinins in the murine neuroblastoma C1300 cell line.
Fukuhara S; Mukai H; Kako K; Nakayama K; Munekata E
J Neurochem; 1996 Sep; 67(3):1282-92. PubMed ID: 8752137
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.
Krause JE; Staveteig PT; Mentzer JN; Schmidt SK; Tucker JB; Brodbeck RM; Bu JY; Karpitskiy VV
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):310-5. PubMed ID: 8990205
[TBL] [Abstract][Full Text] [Related]
9. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
11. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
12. Independent coupling of the human tachykinin NK2 receptor to phospholipases C and A2 in transfected Chinese hamster ovary cells.
Catalioto RM; Cucchi P; Renzetti AR; Criscuoli M; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):395-403. PubMed ID: 9826060
[TBL] [Abstract][Full Text] [Related]
13. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
14. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
16. Bronchoconstrictor effect of the tachykinin NK₃-receptor agonists [MePhe⁷]-neurokinin B and senktide in the isolated guinea pig lung.
Corboz MR; Rivelli MA; Eckel SP
Exp Lung Res; 2010 Nov; 36(9):509-21. PubMed ID: 20939761
[TBL] [Abstract][Full Text] [Related]
17. Cellular pathways mediating tachykinin-evoked secretomotor responses in guinea pig ileum.
MacNaughton W; Moore B; Vanner S
Am J Physiol; 1997 Nov; 273(5):G1127-34. PubMed ID: 9374711
[TBL] [Abstract][Full Text] [Related]
18. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606
[TBL] [Abstract][Full Text] [Related]
19. The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors.
Chung FZ; Wu LH; Vartanian MA; Watling KJ; Guard S; Woodruff GN; Oxender DL
Biochem Biophys Res Commun; 1994 Feb; 198(3):967-72. PubMed ID: 8117304
[TBL] [Abstract][Full Text] [Related]
20. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
Gether U; Johansen TE; Schwartz TW
J Biol Chem; 1993 Apr; 268(11):7893-8. PubMed ID: 7681831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
